Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.77 |
| ▸ | MAPT | P10636 | 6/20 | 0.77 |
| ▸ | HPGD | P15428 | 5/20 | 0.77 |
| ▸ | BLM | P54132 | 5/20 | 0.77 |
| ▸ | RECQL | P46063 | 5/20 | 0.77 |
| ▸ | MEN1 | O00255 | 4/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.77 |
| ▸ | APEX1 | P27695 | 3/20 | 0.77 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.77 |
| ▸ | POLB | P06746 | 3/20 | 0.77 |
| ▸ | GAA | P10253 | 3/20 | 0.77 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.77 |
| ▸ | CA12 | O43570 | 2/20 | 0.77 |
| ▸ | CA1 | P00915 | 2/20 | 0.77 |
| ▸ | CA7 | P43166 | 2/20 | 0.77 |
| ▸ | CA9 | Q16790 | 2/20 | 0.77 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.77 |
| ▸ | PKLR | P30613 | 2/20 | 0.77 |
| ▸ | GALNT2 | Q10471 | 2/20 | 0.77 |
| ▸ | LMNA | P02545 | 2/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ellagic Acid SCHEMBL29439360 | 0.88 | KDM4E (1.00) | KDM4EMAPTHPGDBLMRECQL | |
| Ellagic Acid SCHEMBL1645767 | 0.88 | KDM4E (1.00) | KDM4EMAPTHPGDBLMRECQL | |
| Ellagic Acid SCHEMBL20429 | 0.88 | KDM4E (1.00) | KDM4EMAPTHPGDBLMRECQL | |
| Ellagic Acid SCHEMBL30475160 | 0.88 | KDM4E (1.00) | KDM4EMAPTHPGDBLMRECQL | |
| SCHEMBL2355138 | 0.87 | KDM4E (0.88) | KDM4EMAPTHPGDBLMRECQL | |
| Ellagic Acid SCHEMBL9146254 | 0.86 | KDM4E (0.96) | KDM4EMAPTHPGDBLMRECQL | |
| Ellagic Acid SCHEMBL8686557 | 0.86 | KDM4E (0.96) | KDM4EMAPTHPGDBLMRECQL | |
| Ellagic Acid SCHEMBL21590140 | 0.86 | KDM4E (0.96) | KDM4EMAPTHPGDBLMRECQL | |
| Ellagic Acid SCHEMBL8686551 | 0.86 | KDM4E (0.96) | KDM4EMAPTHPGDBLMRECQL | |
| Ellagic Acid SCHEMBL177722 | 0.86 | KDM4E (0.96) | KDM4EMAPTHPGDBLMRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3091958-A1 | COSMETIC COMPOSITION COMPRISING CATIONIC SURFACTANT(S), ANTIDANDRUFF AGENT(S), LIQUID NON-SILICEOUS FATTY SUBSTANCE(S), AND NON-POLYMERIC THICKENING AGENT(S) | L'OREAL (FR) | 2016-11-16 | — | — | EP | claimed |
| US-20150174025-A1 | COMPOSITION COMPRISING ELLAGIC ACID AND A PARTICULAR CATIONIC SURFACTANT, AND COSMETIC USE THEREOF | OREAL (FR) | 2015-06-25 | — | — | US | claimed |
| WO-2015085376-A1 | COSMETIC COMPOSITION COMPRISING CATIONIC SURFACTANT(S), ANTIDANDRUFF AGENT(S), LIQUID NON-SILICEOUS FATTY SUBSTANCE(S), AND NON-POLYMERIC THICKENING AGENT(S) | L'OREAL (FR) | 2015-06-18 | — | — | WO | claimed |
| US-20130195776-A1 | COSMETIC COMPOSITION BASED ON ELLAGIC ACID OR A DERIVATIVE THEREOF AND A BACTERIAL EXTRACT | L'OREAL S.A. (FR) | 2013-08-01 | — | — | US | claimed |
| US-20130112218-A1 | USE OF ELLAGIC ACID AS AN ANTI-DANDRUFF AGENT | DERKX TIPHAINE (FR) | 2013-05-09 | — | — | US | claimed |
| US-20130109746-A1 | COMPOSITION COMPRISING ELLAGIC ACID AND A PARTICULAR CATIONIC SURFACTANT, AND COSMETIC USE THEREOF | L'OREAL S.A. (FR) | 2013-05-02 | — | — | US | claimed |
| CN-103037835-A | Cosmetic composition based on ellagic acid or a derivative thereof and on a particular mixture of surfactants | OREAL | 2013-04-10 | — | — | CN | claimed |
| US-20130085177-A1 | COSMETIC COMPOSITION BASED ON ELLAGIC ACID OR A DERIVATIVE THEREOF AND ON A PARTICULAR MIXTURE OF SURFACTANTS | L'OREAL (FR) | 2013-04-04 | — | — | US | claimed |
| EP-2542216-A2 | COSMETIC COMPOSITION BASED ON ELLAGIC ACID OR A DERIVATIVE THEREOF AND ON A PARTICULAR MIXTURE OF SURFACTANTS | L'Oréal (FR) | 2013-01-09 | — | — | EP | claimed |
| EP-2542218-A1 | USE OF ELLAGIC ACID AS AN ANTI-DANDRUFF AGENT | L'Oréal (FR) | 2013-01-09 | — | — | EP | claimed |
| CN-102781418-A | Use of ellagic acid as an anti-dandruff agent | OREAL | 2012-11-14 | — | — | CN | claimed |
| WO-2011107469-A1 | USE OF ELLAGIC ACID AS AN ANTI-DANDRUFF AGENT | L'OREAL (FR) | 2011-09-09 | — | — | WO | claimed |
| WO-2011107467-A2 | COSMETIC COMPOSITION BASED ON ELLAGIC ACID OR A DERIVATIVE THEREOF AND ON A PARTICULAR MIXTURE OF SURFACTANTS | L'OREAL (FR) | 2011-09-09 | — | — | WO | claimed |
| WO-2024126540-A1 | COSMETIC COMPOSITION COMPRISING NIACINAMIDE, A GINGER ROOT EXTRACT, A CARBOXYLIC ACRYLIC POLYMER, AN ACTIVE AGENT FOR COMBATING HAIR LOSS AND/OR AN ANTI-DANDRUFF ACTIVE AGENT | L'OREAL (FR) | 2024-06-20 | — | — | WO | disclosed |
| WO-2023176783-A1 | SOLID COMPOSITION | 第一三共ヘルスケア株式会社 | 2023-09-21 | — | — | WO | disclosed |
| US-10555890-B2 | Flexible solid cosmetic composition comprising anionic surfactants and solid particles, and cosmetic treatment process | L'OREAL (FR) | 2020-02-11 | — | — | US | disclosed |
| WO-2011107433-A2 | COSMETIC COMPOSITION BASED ON ELLAGIC ACID OR A DERIVATIVE THEREOF AND A BACTERIAL EXTRACT | L'OREAL (FR) | 2011-09-09 | — | — | WO | disclosed |
| EP-1586315-B1 | SKIN LIGHTENING COMPOSITION | DAIICHI SANKYO HEALTHCARE CO (JP) | 2010-04-14 | — | — | EP | disclosed |
| US-20060142382-A1 | Skin lightening composition | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2006-06-29 | — | — | US | disclosed |
| EP-1586315-A1 | SKIN LIGHTENING COMPOSITION | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2005-10-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130112218-A1 | USE OF ELLAGIC ACID AS AN ANTI-DANDRUFF AGENT | ETF1, ELANE, PRKDC | KDM4E 1206/4885MAPT 2716/4885HPGD 684/4885 |
| US-20130085177-A1 | COSMETIC COMPOSITION BASED ON ELLAGIC ACID OR A DERIVATIVE THEREOF AND ON A PARTICULAR MIXTURE OF SURFACTANTS | KRT18, DSG1, ELL | KDM4E 402/4885MAPT 1874/4885HPGD 2452/4885 |
| US-20150174025-A1 | COMPOSITION COMPRISING ELLAGIC ACID AND A PARTICULAR CATIONIC SURFACTANT, AND COSMETIC USE THEREOF | PRKDC, KRT18, SMURF1 | KDM4E 1304/4885MAPT 2749/4885HPGD 1429/4885 |
| US-10555890-B2 | Flexible solid cosmetic composition comprising anionic surfactants and solid particles, and cosmetic treatment process | CUTA, KRT18, KAT7 | KDM4E 367/4885MAPT 1853/4885HPGD 2808/4885 |
| US-20130195776-A1 | COSMETIC COMPOSITION BASED ON ELLAGIC ACID OR A DERIVATIVE THEREOF AND A BACTERIAL EXTRACT | CUTA, PRKDC, FEN1 | KDM4E 2459/4885MAPT 1507/4885HPGD 1309/4885 |
| US-20130109746-A1 | COMPOSITION COMPRISING ELLAGIC ACID AND A PARTICULAR CATIONIC SURFACTANT, AND COSMETIC USE THEREOF | PRKDC, KRT18, S100A10 | KDM4E 1467/4885MAPT 2197/4885HPGD 1063/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.